
Background Although attachment characteristics are associated with sinonasal papilloma recurrence, the independent associations of multiple attachment sites and broad-based attachment remain incompletely defined. Objective This study evaluated clinical, histological, and surgical predictors of sinonasal papilloma recurrence, emphasizing multiple and broad-based attachment. Methods A single-center retrospective cohort study was conducted including 178 patients who underwent surgical treatment for sinonasal papilloma between January 2006 and December 2021. Demographic, clinical, and histopathological variables—such as number of surgeries, origin of attachment site, histological subtype, presence of multiple attachment sites, broad-based attachment, follow-up duration, recurrence status, and time to recurrence—were extracted from medical records, operative notes, and surgical videos. Binomial logistic regression was used to identify independent predictors of recurrence. Results The cohort included 178 patients, of whom 167 (93.8%) had inverted papilloma. The mean age was 52.2 ± 7.9 years, and 84.3% of patients were male. The median follow-up duration was 86.9 months (IQR:64.9-100.8). Thirty-one patients (17.4%) were revision cases. Recurrence occurred in 20 patients (11.2%), with a median time to recurrence of 26.4 months (IQR 10.1-45.7). No significant differences were observed between recurrence and nonrecurrence groups regarding age, sex, or histological type ( p > 0.05). However, recurrence was significantly associated with the origin of attachment site (frontal sinus), revision cases, multiple attachment sites, and broad-based attachment ( p < 0.05). In multivariate analysis, only multiple attachment sites (OR = 18.7, 95% CI:2.6-133.8, p = 0.004) and broad-based attachment (OR = 13.3, 95% CI:2.3-76.9, p = 0.004) remained independently associated with recurrence. Conclusion Multiple attachment sites and broad-based attachment significantly increase recurrence risk—approximately 19- and 13-fold, respectively—highlighting the importance of thorough intraoperative evaluation and complete resection of all tumor attachment sites.
Background Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) who fail medical management are often offered endoscopic sinus surgery (ESS). Dupilumab is also used to treat patients with inadequately controlled CRSwNP. Objective This retrospective cohort study uses a national registry to examine the patterns in healthcare utilization in patients with CRSwNP. Methods A review of the AAO-HNSF Reg-ent(SM) data registry of CRSwNP patients who underwent ESS or received dupilumab from 2019 to 2025 was performed. The primary outcome of oral antibiotic and corticosteroid free-probability was summarized by Kaplan-Meier estimates and compared between dupilumab treatment and surgery by piecewise Cox proportional hazards model with follow-up time split at 6 months while adjusting for age, sex, ethnicity, race, history of asthma, and allergic rhinitis. Secondary outcomes include polyp recurrence/persistence and repeat imaging. Results 12,944 patients were included. Kaplan-Meier analysis demonstrated the hazard ratio changing over time indicating lower relative hazard of post-intervention antibiotics/corticosteroid use early on among patients who were treated with dupilumab, but the relative hazard of the group increased over time. Antibiotic/corticosteroid use was lower among dupilumab treated patients compared to ESS patients (HR = 0.873; aHR = 0.740; p < 0.0001) in the first 6 months, but they demonstrated higher antibiotic/corticosteroid use thereafter (HR = 1.60, aHR = 1.279; p < 0.0012). There was an increased risk of nasal polyp recurrence/persistence in the dupilumab group during both time periods (aHR = 1.189 & 2.040 before and after 6 months, p < 0.0005 & 0.0001). During the first 6 months, the hazard of repeat imaging was higher among dupilumab patients compared to ESS patients (aHR = 2.098; p < 0.0001). After 6 months, the hazard among dupilumab patients was lower than the ESS patients (aHR = 0.409, p < 0.0001). Conclusion CRSwNP patients treated with dupilumab and ESS demonstrated variable healthcare utilization over time, highlighting the importance of patient selection and shared decision making when considering initiation of dupilumab therapy for CRSwNP.
Background Tissue eosinophil counts are commonly used as prognostic markers in chronic rhinosinusitis with nasal polyps (CRSwNP) and to determine eligibility for financial assistance based on established criteria, highlighting an evolving importance. However, no standardized protocols govern specimen handling from collection to formalin fixation yet. This gap in practice is clinically meaningful, as the effect of pre-fixation delay on eosinophil counts and epithelial integrity remains poorly defined. Objective To determine whether time to formalin fixation influences eosinophil counts and epithelial integrity in nasal polyps from patients with CRSwNP. Methods Clinical nasal polyp specimens processed through our institution's standard surgical pathology workflow and a controlled research protocol were evaluated histologically with hematoxylin and eosin staining. For clinical specimens, time from collection to fixation was recorded and eosinophils were enumerated. In the experimental portion, research specimens were sectioned and fixed at 0 h, 1 day, 3 days, and 7 days after excision. Eosinophil counts and epithelial injury scores were compared across time intervals and correlated with fixation delay. Results Time to formalin fixation ranged from 51 min to 19 h, and longer delays correlated with greater eosinophil reduction ( r = −0.867, p = .057). In the experimental portion, eosinophil counts were lower at 1, 3, and 7 days than at 0 h ( p < .05), and fixation time was negatively correlated with eosinophil count ( r = −0.39, p < .05). Epithelial injury scores increased at 1, 3, and 7 days ( p < .05), and positively correlated with fixation time ( r = 0.72, p < .05). Conclusions Delayed formalin fixation reduces eosinophil counts and worsens epithelial preservation in nasal polyps. Standardization of tissue handling and fixation timing may improve the reliability of histologic eosinophil assessment in CRSwNP patients.
Background: Chronic rhinosinusitis (CRS) is a common disease that markedly impairs quality of life. Although Ramadan fasting (RF) has demonstrated influences on nasal physiology, its effects on sinonasal symptoms in CRS patients remain unclear. Objective: This study aimed to investigate the symptom changes of patients with CRS during RF. Methods: This prospective study included 42 male CRS patients and 42 healthy male individuals. Participants underwent nasal endoscopic evaluations, and their Lund-Kennedy scores were recorded. Sinonasal symptoms, including nasal congestion, nasal discharge, postnasal drip, olfactory disturbance, facial pain/pressure, headache, and overall symptoms, were assessed using a visual analog scale (VAS) on day 0, the first and last days of RF (days 1 and 30), and at the study's end (day 210). Participants' body weights were recorded on days 0 and 210, and the collected data were analyzed statistically. Results: The patients' scores were significantly higher than those of healthy individuals on all study days. Significant differences were observed in nasal congestion, nasal discharge, postnasal drip, olfactory disturbance, and overall symptoms at various study periods. On day 0, scores for nasal congestion, nasal discharge, and postnasal drip were significantly higher than on days 1 and 30. Olfactory disturbance and overall symptoms were also higher on day 0 compared to day 30. On day 210, nasal discharge and postnasal drip scores were significantly higher than on days 1 and 30, while nasal congestion, olfactory disturbance, and overall symptoms were higher than on day 30 (p < 0.05). Conclusion: This study demonstrated that RF was associated with temporary improvement in nasal congestion, nasal discharge, postnasal drip, olfactory disturbance, and overall sinonasal symptoms in CRS patients.
Objective This study aims to express and purify staphylococcal enterotoxin B (SEB) and to detect and analyze the levels of SEB-specific IgG antibodies in the serum of children with food or aeroallergen allergies using an enzyme-linked immunosorbent assay (ELISA). Methods SEB protein was expressed and purified in a recombinant pET-28 alpha(+)-SEB E. coli system. The purified SEB protein was used as an antigen to detect SEB-IgG antibody levels in the serum of 100 clinically confirmed cases of food-allergic and aeroallergen-allergic children, and the results were compared with those of 50 healthy children using ELISA. Results The recombinant SEB protein, with a molecular weight of approximately 35 kDa, was successfully expressed and purified. ELISA results showed that the SEB-IgG antibody levels in the serum of food-allergic and aeroallergen-allergic children (OD450 values of 0.30 +/- 0.03 and 0.31 +/- 0.04, respectively) were significantly higher than those in the normal control group (0.24 +/- 0.05, P < .05). However, there was no significant difference in SEB-IgG antibody levels between food-allergic children and aeroallergen-allergic children (P > .05). The positive rate of SEB-IgG antibodies was 68% in aeroallergen-allergic children and 56% in food-allergic children. SEB-IgG positivity increased with the number of allergens but was not correlated with the severity of the allergy. Conclusion This study successfully expressed and purified SEB protein in a prokaryotic system. We found that SEB-IgG antibody levels were significantly higher in allergic children compared to healthy controls and were related to the number of allergens. These results suggest an association between SEB exposure and allergic diseases in the pediatric population, highlighting its potential role as an immunomodulator and laying a foundation for further mechanistic and clinical investigations.